Literature DB >> 12640129

Supramolecular complex formation between Rad6 and proteins of the p53 pathway during DNA damage-induced response.

Alex Lyakhovich1, Malathy P V Shekhar.   

Abstract

The HR6A and -B genes, homologues of the yeast Rad6 gene, encode ubiquitin-conjugating enzymes that are required for postreplication repair of DNA and damage-induced mutagenesis. Using surface plasmon resonance, we show here that HR6 protein (referred as Rad6) physically interacts with p53. Analysis of proteins coimmunoprecipitated with Rad6 antibody from metabolically labeled normal MCF10A human breast epithelial cells not only confirmed Rad6-p53 interactions in vivo but also demonstrated for the first time that exposure of MCF10A cells to cisplatin or adriamycin (ADR) induces recruitment of p14ARF into Rad6-p53 complexes. Further analysis of ADR-induced p53 response showed that stable Rad6-p53-p14ARF complex formation is associated with a parallel increase and decrease in monoubiquitinated and polyubiquitinated p53, respectively, and arrest in G(2)/M phase of the cell cycle. Interestingly, the ADR-induced suppression of p53 polyubiquitination correlated with a corresponding decline in intact Hdm2 protein levels. Treatment of MCF10A cells with MG132, a 26S proteasome inhibitor, effectively stabilized monoubiquitinated p53 and rescued ADR-induced downregulation of Hdm2. These data suggest that ADR-induced degradation of Hdm2 occurs via the ubiquitin-proteasome pathway. Rad6 is present in both the cytoplasmic and nuclear compartments of normal MCF10A cells, although in response to DNA damage it is predominantly found in the nucleus colocalizing with ubiquitinated p53, whereas Hdm2 is undetectable. Consistent with in vivo data, results from in vitro ubiquitination assays show that Rad6 mediates addition of one (mono-) to two (multimono-) ubiquitin molecules on p53 and that inclusion of Mdm2 is essential for its polyubiquitination. The data presented in the present study suggest that Rad6-p53-p14ARF complex formation and p53 ubiquitin modification are important damage-induced responses that perhaps determine the fidelity of DNA postreplication repair.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12640129      PMCID: PMC150718          DOI: 10.1128/MCB.23.7.2463-2475.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

Review 1.  The two faces of tumor suppressor p53.

Authors:  M L Smith; A J Fornace
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

2.  Physical interaction between specific E2 and Hect E3 enzymes determines functional cooperativity.

Authors:  S Kumar; W H Kao; P M Howley
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

3.  Rad6-dependent ubiquitination of histone H2B in yeast.

Authors:  K Robzyk; J Recht; M A Osley
Journal:  Science       Date:  2000-01-21       Impact factor: 47.728

4.  Domains required for dimerization of yeast Rad6 ubiquitin-conjugating enzyme and Rad18 DNA binding protein.

Authors:  V Bailly; S Prakash; L Prakash
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

5.  Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair.

Authors:  R M Hofmann; C M Pickart
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

6.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

7.  Yeast DNA repair proteins Rad6 and Rad18 form a heterodimer that has ubiquitin conjugating, DNA binding, and ATP hydrolytic activities.

Authors:  V Bailly; S Lauder; S Prakash; L Prakash
Journal:  J Biol Chem       Date:  1997-09-12       Impact factor: 5.157

8.  ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

Authors:  Y Zhang; Y Xiong; W G Yarbrough
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

9.  Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant.

Authors:  D Finley; S Sadis; B P Monia; P Boucher; D J Ecker; S T Crooke; V Chau
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

10.  Yeast RAD6 encoded ubiquitin conjugating enzyme mediates protein degradation dependent on the N-end-recognizing E3 enzyme.

Authors:  P Sung; E Berleth; C Pickart; S Prakash; L Prakash
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

View more
  18 in total

1.  BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number.

Authors:  Lea M Starita; Yuka Machida; Satish Sankaran; Joshua E Elias; Karen Griffin; Brian P Schlegel; Steven P Gygi; Jeffrey D Parvin
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

2.  Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2.

Authors:  Jonathan Shloush; John E Vlassov; Ian Engson; Shili Duan; Vivian Saridakis; Sirano Dhe-Paganon; Brian Raught; Yi Sheng; Cheryl H Arrowsmith
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

3.  Identification and characterization of a ubiquitinconjugating enzyme UBE2A gene from lamprey.

Authors:  Liyong Chen; Fenfang Wu; Bo Feng
Journal:  Fish Physiol Biochem       Date:  2016-02       Impact factor: 2.794

4.  Utility of DNA postreplication repair protein Rad6B in neoadjuvant chemotherapy response.

Authors:  Malathy P V Shekhar; Laura A Biernat; Nat Pernick; Larry Tait; Judith Abrams; Daniel W Visscher
Journal:  Med Oncol       Date:  2009-05-23       Impact factor: 3.064

5.  The Rad6/18 ubiquitin complex interacts with the Epstein-Barr virus deubiquitinating enzyme, BPLF1, and contributes to virus infectivity.

Authors:  Ravindra Kumar; Christopher B Whitehurst; Joseph S Pagano
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

6.  E2 ligase dRad6 regulates DMP53 turnover in Drosophila.

Authors:  Su Chen; Hui-Min Wei; Wen-Wen Lv; Da-Liang Wang; Fang-Lin Sun
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

7.  Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.

Authors:  Matthew A Sanders; Brittany Haynes; Pratima Nangia-Makker; Lisa A Polin; Malathy P Shekhar
Journal:  J Biol Chem       Date:  2017-05-10       Impact factor: 5.157

8.  MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation.

Authors:  Jer-Yen Yang; Cong S Zong; Weiya Xia; Yongkun Wei; Mohamed Ali-Seyed; Zheng Li; Kristine Broglio; Donald A Berry; Mien-Chie Hung
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

9.  RAD6 regulates the dosage of p53 by a combination of transcriptional and posttranscriptional mechanisms.

Authors:  Su Chen; Da-Liang Wang; Yan Liu; Lei Zhao; Fang-Lin Sun
Journal:  Mol Cell Biol       Date:  2011-11-14       Impact factor: 4.272

10.  Global changes in processing of mRNA 3' untranslated regions characterize clinically distinct cancer subtypes.

Authors:  Priyam Singh; Travis L Alley; Sarah M Wright; Sonya Kamdar; William Schott; Robert Y Wilpan; Kevin D Mills; Joel H Graber
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.